0.027270
0.015744
0.000000
0.000000
0.031489
0.000000
0.000000
0.000000
0.006926
0.00000
0.00000
0.00000
Saraboji, K.
Nordlund, A.
Leinartait, L.
Oliveberg, M.
Logan, D.T.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
6
90.00
90.00
120.00
36.670
36.670
144.390
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
Zn 2
65.409
ZINC ION
non-polymer
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
106
9667
9672
10.1073/pnas.0812046106
19497878
Functional features cause misfolding of the ALS-provoking enzyme SOD1.
2009
10.2210/pdb3hff/pdb
pdb_00003hff
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100
1
CCD
2008-10-22
MAR CCD 165 mm
SINGLE WAVELENGTH
M
x-ray
1
0.9083
1.0
I911-5
MAX II
0.9083
SYNCHROTRON
MAX II BEAMLINE I911-5
15636.213
Superoxide dismutase [Cu-Zn]
1.15.1.1
C6A, C111A, F50E, G51E, H63S, H71S, H80S, D83S
1
man
polymer
65.409
ZINC ION
5
syn
non-polymer
18.015
water
28
nat
water
CU/ZN SUPEROXIDE DISMUTASE
no
no
ATKAVAVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEEEDNTAGCTSAGPSFNPLSRKSGGPKDEERS
VGSLGNVTADKDGVADVSIEDSVISLSGDHAIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ
ATKAVAVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEEEDNTAGCTSAGPSFNPLSRKSGGPKDEERS
VGSLGNVTADKDGVADVSIEDSVISLSGDHAIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
sample
SOD1
9606
Homo sapiens
562
Escherichia coli
BL21/DE3
1
1.79
31.50
VAPOR DIFFUSION, HANGING DROP
8.0
16% PEG 6000, 10% Jeffamine M-600 (pH 7.0), 0.1M Tris-HCl (pH 8.0), 0.1M ZnCl2, VAPOR DIFFUSION, HANGING DROP, temperature 293K
293
diffrn_source
software
database_2
struct_ref_seq_dif
struct_site
repository
Initial release
Advisory
Refinement description
Version format compliance
Data collection
Refinement description
Database references
Derived calculations
1
0
2009-06-16
1
1
2011-07-13
1
2
2017-11-01
1
3
2021-11-10
_diffrn_source.pdbx_synchrotron_site
_software.name
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_ref_seq_dif.details
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
RCSB
Y
PDBJ
2009-05-11
REL
REL
ZN
ZINC ION
HOH
water
ZN
154
2
ZN
ZN
154
A
ZN
155
2
ZN
ZN
155
A
ZN
156
2
ZN
ZN
156
A
ZN
158
2
ZN
ZN
158
A
ZN
159
2
ZN
ZN
159
A
HOH
201
3
HOH
HOH
201
A
HOH
202
3
HOH
HOH
202
A
HOH
203
3
HOH
HOH
203
A
HOH
204
3
HOH
HOH
204
A
HOH
205
3
HOH
HOH
205
A
HOH
206
3
HOH
HOH
206
A
HOH
207
3
HOH
HOH
207
A
HOH
208
3
HOH
HOH
208
A
HOH
209
3
HOH
HOH
209
A
HOH
210
3
HOH
HOH
210
A
HOH
211
3
HOH
HOH
211
A
HOH
212
3
HOH
HOH
212
A
HOH
213
3
HOH
HOH
213
A
HOH
214
3
HOH
HOH
214
A
HOH
215
3
HOH
HOH
215
A
HOH
216
3
HOH
HOH
216
A
HOH
217
3
HOH
HOH
217
A
HOH
218
3
HOH
HOH
218
A
HOH
219
3
HOH
HOH
219
A
HOH
220
3
HOH
HOH
220
A
HOH
221
3
HOH
HOH
221
A
HOH
222
3
HOH
HOH
222
A
HOH
223
3
HOH
HOH
223
A
HOH
224
3
HOH
HOH
224
A
HOH
225
3
HOH
HOH
225
A
HOH
226
3
HOH
HOH
226
A
HOH
227
3
HOH
HOH
227
A
HOH
228
3
HOH
HOH
228
A
ALA
1
n
1
ALA
1
A
THR
2
n
2
THR
2
A
LYS
3
n
3
LYS
3
A
ALA
4
n
4
ALA
4
A
VAL
5
n
5
VAL
5
A
ALA
6
n
6
ALA
6
A
VAL
7
n
7
VAL
7
A
LEU
8
n
8
LEU
8
A
LYS
9
n
9
LYS
9
A
GLY
10
n
10
GLY
10
A
ASP
11
n
11
ASP
11
A
GLY
12
n
12
GLY
12
A
PRO
13
n
13
PRO
13
A
VAL
14
n
14
VAL
14
A
GLN
15
n
15
GLN
15
A
GLY
16
n
16
GLY
16
A
ILE
17
n
17
ILE
17
A
ILE
18
n
18
ILE
18
A
ASN
19
n
19
ASN
19
A
PHE
20
n
20
PHE
20
A
GLU
21
n
21
GLU
21
A
GLN
22
n
22
GLN
22
A
LYS
23
n
23
LYS
23
A
GLU
24
n
24
GLU
24
A
SER
25
n
25
SER
25
A
ASN
26
n
26
ASN
26
A
GLY
27
n
27
GLY
27
A
PRO
28
n
28
PRO
28
A
VAL
29
n
29
VAL
29
A
LYS
30
n
30
LYS
30
A
VAL
31
n
31
VAL
31
A
TRP
32
n
32
TRP
32
A
GLY
33
n
33
GLY
33
A
SER
34
n
34
SER
34
A
ILE
35
n
35
ILE
35
A
LYS
36
n
36
LYS
36
A
GLY
37
n
37
GLY
37
A
LEU
38
n
38
LEU
38
A
THR
39
n
39
THR
39
A
GLU
40
n
40
GLU
40
A
GLY
41
n
41
GLY
41
A
LEU
42
n
42
LEU
42
A
HIS
43
n
43
HIS
43
A
GLY
44
n
44
GLY
44
A
PHE
45
n
45
PHE
45
A
HIS
46
n
46
HIS
46
A
VAL
47
n
47
VAL
47
A
HIS
48
n
48
HIS
48
A
GLU
49
n
49
GLU
49
A
GLU
50
n
50
GLU
50
A
n
51
51
A
n
52
52
A
n
53
53
A
n
54
54
A
n
55
55
A
n
56
56
A
n
57
57
A
n
58
58
A
n
59
59
A
n
60
60
A
n
61
61
A
n
62
62
A
n
63
63
A
n
64
64
A
n
65
65
A
n
66
66
A
n
67
67
A
n
68
68
A
n
69
69
A
n
70
70
A
n
71
71
A
n
72
72
A
n
73
73
A
n
74
74
A
n
75
75
A
n
76
76
A
n
77
77
A
n
78
78
A
n
79
79
A
n
80
80
A
VAL
81
n
81
VAL
81
A
GLY
82
n
82
GLY
82
A
SER
83
n
83
SER
83
A
LEU
84
n
84
LEU
84
A
GLY
85
n
85
GLY
85
A
ASN
86
n
86
ASN
86
A
VAL
87
n
87
VAL
87
A
THR
88
n
88
THR
88
A
ALA
89
n
89
ALA
89
A
ASP
90
n
90
ASP
90
A
LYS
91
n
91
LYS
91
A
ASP
92
n
92
ASP
92
A
GLY
93
n
93
GLY
93
A
VAL
94
n
94
VAL
94
A
ALA
95
n
95
ALA
95
A
ASP
96
n
96
ASP
96
A
VAL
97
n
97
VAL
97
A
SER
98
n
98
SER
98
A
ILE
99
n
99
ILE
99
A
GLU
100
n
100
GLU
100
A
ASP
101
n
101
ASP
101
A
SER
102
n
102
SER
102
A
VAL
103
n
103
VAL
103
A
ILE
104
n
104
ILE
104
A
SER
105
n
105
SER
105
A
LEU
106
n
106
LEU
106
A
SER
107
n
107
SER
107
A
GLY
108
n
108
GLY
108
A
ASP
109
n
109
ASP
109
A
HIS
110
n
110
HIS
110
A
ALA
111
n
111
ALA
111
A
ILE
112
n
112
ILE
112
A
ILE
113
n
113
ILE
113
A
GLY
114
n
114
GLY
114
A
ARG
115
n
115
ARG
115
A
THR
116
n
116
THR
116
A
LEU
117
n
117
LEU
117
A
VAL
118
n
118
VAL
118
A
VAL
119
n
119
VAL
119
A
HIS
120
n
120
HIS
120
A
GLU
121
n
121
GLU
121
A
LYS
122
n
122
LYS
122
A
ALA
123
n
123
ALA
123
A
ASP
124
n
124
ASP
124
A
ASP
125
n
125
ASP
125
A
LEU
126
n
126
LEU
126
A
GLY
127
n
127
GLY
127
A
LYS
128
n
128
LYS
128
A
GLY
129
n
129
GLY
129
A
GLY
130
n
130
GLY
130
A
ASN
131
n
131
ASN
131
A
n
132
132
A
n
133
133
A
n
134
134
A
n
135
135
A
n
136
136
A
n
137
137
A
n
138
138
A
ASN
139
n
139
ASN
139
A
ALA
140
n
140
ALA
140
A
GLY
141
n
141
GLY
141
A
SER
142
n
142
SER
142
A
ARG
143
n
143
ARG
143
A
LEU
144
n
144
LEU
144
A
ALA
145
n
145
ALA
145
A
CYS
146
n
146
CYS
146
A
GLY
147
n
147
GLY
147
A
VAL
148
n
148
VAL
148
A
ILE
149
n
149
ILE
149
A
GLY
150
n
150
GLY
150
A
ILE
151
n
151
ILE
151
A
ALA
152
n
152
ALA
152
A
n
153
153
A
2.2575
-0.1098
0.5447
3.2447
-1.4004
5.6545
-0.0025
-0.1628
0.0625
-0.0368
-0.0899
-0.1844
-0.1830
0.2118
0.0925
0.0363
-0.0429
0.0156
0.0721
-0.0026
0.0888
refined
15.1292
-15.9840
10.2232
X-RAY DIFFRACTION
A
1
A
152
X-RAY DIFFRACTION
1
author_defined_assembly
1
monomeric
software_defined_assembly
PISA
2
dimeric
1130
-6
11820
A
ALA
1
A
N
ALA
1
1_555
A
ZN
156
D
ZN
ZN
1_555
A
ALA
1
A
O
ALA
1
1_555
77.7
A
ALA
1
A
N
ALA
1
1_555
A
ZN
156
D
ZN
ZN
1_555
A
HOH
206
G
O
HOH
1_555
87.1
A
ALA
1
A
O
ALA
1
1_555
A
ZN
156
D
ZN
ZN
1_555
A
HOH
206
G
O
HOH
1_555
163.7
A
ALA
1
A
N
ALA
1
1_555
A
ZN
156
D
ZN
ZN
1_555
A
HOH
209
G
O
HOH
1_555
108.8
A
ALA
1
A
O
ALA
1
1_555
A
ZN
156
D
ZN
ZN
1_555
A
HOH
209
G
O
HOH
1_555
94.6
A
HOH
206
G
O
HOH
1_555
A
ZN
156
D
ZN
ZN
1_555
A
HOH
209
G
O
HOH
1_555
95.9
A
HIS
46
A
ND1
HIS
46
1_555
A
ZN
154
B
ZN
ZN
1_555
A
HIS
120
A
NE2
HIS
120
1_555
98.8
A
HIS
46
A
ND1
HIS
46
1_555
A
ZN
154
B
ZN
ZN
1_555
A
HOH
211
G
O
HOH
1_555
95.7
A
HIS
120
A
NE2
HIS
120
1_555
A
ZN
154
B
ZN
ZN
1_555
A
HOH
211
G
O
HOH
1_555
104.8
A
ASP
90
A
OD2
ASP
90
1_555
A
ZN
155
C
ZN
ZN
1_555
A
HOH
208
G
O
HOH
1_555
111.9
A
ASP
125
A
OD2
ASP
125
1_555
A
ZN
159
F
ZN
ZN
1_555
A
HOH
219
G
O
HOH
1_555
114.5
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-0.5000000000
-0.8660254038
0.0000000000
-0.8660254038
0.5000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
6_555
-x,-x+y,-z+1/3
crystal symmetry operation
0.0000000000
0.0000000000
48.1300000000
A
O
ALA
89
A
O
ALA
89
A
N
GLY
41
A
N
GLY
41
A
N
GLY
44
A
N
GLY
44
A
O
HIS
120
A
O
HIS
120
A
N
LEU
117
A
N
LEU
117
A
O
GLY
147
A
O
GLY
147
A
O
CYS
146
A
O
CYS
146
A
N
LYS
9
A
N
LYS
9
A
N
LEU
8
A
N
LEU
8
A
O
GLY
16
A
O
GLY
16
A
N
ASN
19
A
N
ASN
19
A
O
TRP
32
A
O
TRP
32
A
N
GLY
33
A
N
GLY
33
A
O
VAL
97
A
O
VAL
97
A
O
ALA
89
A
O
ALA
89
A
N
GLY
41
A
N
GLY
41
A
N
GLY
44
A
N
GLY
44
A
O
HIS
120
A
O
HIS
120
A
N
LEU
117
A
N
LEU
117
A
O
GLY
147
A
O
GLY
147
A
O
CYS
146
A
O
CYS
146
A
N
LYS
9
A
N
LYS
9
A
N
VAL
5
A
N
VAL
5
A
O
GLY
150
A
O
GLY
150
1
A
CD
LYS
122
A
CD
LYS
122
1
Y
1
A
CE
LYS
122
A
CE
LYS
122
1
Y
1
A
NZ
LYS
122
A
NZ
LYS
122
1
Y
1
A
GLU
51
A
GLU
51
1
Y
1
A
ASP
52
A
ASP
52
1
Y
1
A
ASN
53
A
ASN
53
1
Y
1
A
THR
54
A
THR
54
1
Y
1
A
ALA
55
A
ALA
55
1
Y
1
A
GLY
56
A
GLY
56
1
Y
1
A
CYS
57
A
CYS
57
1
Y
1
A
THR
58
A
THR
58
1
Y
1
A
SER
59
A
SER
59
1
Y
1
A
ALA
60
A
ALA
60
1
Y
1
A
GLY
61
A
GLY
61
1
Y
1
A
PRO
62
A
PRO
62
1
Y
1
A
SER
63
A
SER
63
1
Y
1
A
PHE
64
A
PHE
64
1
Y
1
A
ASN
65
A
ASN
65
1
Y
1
A
PRO
66
A
PRO
66
1
Y
1
A
LEU
67
A
LEU
67
1
Y
1
A
SER
68
A
SER
68
1
Y
1
A
ARG
69
A
ARG
69
1
Y
1
A
LYS
70
A
LYS
70
1
Y
1
A
SER
71
A
SER
71
1
Y
1
A
GLY
72
A
GLY
72
1
Y
1
A
GLY
73
A
GLY
73
1
Y
1
A
PRO
74
A
PRO
74
1
Y
1
A
LYS
75
A
LYS
75
1
Y
1
A
ASP
76
A
ASP
76
1
Y
1
A
GLU
77
A
GLU
77
1
Y
1
A
GLU
78
A
GLU
78
1
Y
1
A
ARG
79
A
ARG
79
1
Y
1
A
SER
80
A
SER
80
1
Y
1
A
GLU
132
A
GLU
132
1
Y
1
A
GLU
133
A
GLU
133
1
Y
1
A
SER
134
A
SER
134
1
Y
1
A
THR
135
A
THR
135
1
Y
1
A
LYS
136
A
LYS
136
1
Y
1
A
THR
137
A
THR
137
1
Y
1
A
GLY
138
A
GLY
138
1
Y
1
A
GLN
153
A
GLN
153
1
Y
1
A
A
O
O
HIS
HOH
110
224
2.13
1
A
HIS
110
-118.07
50.16
23.170
-0.02
-0.01
0.00
-0.02
0.00
0.03
0.937
0.902
HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS
0.28087
0.22363
0.22914
2.20
17.13
559
5250
9.6
93.47
16.876
0.217
RANDOM
LIKELY RESIDUAL
1
THROUGHOUT
0
MOLECULAR REPLACEMENT
0.355
0.263
0.80
0.80
1.40
MAXIMUM LIKELIHOOD
MASK
2.20
17.13
28
851
5
0
818
0.015
0.021
828
0.001
0.020
529
1.397
1.950
1116
1.743
3.000
1310
6.839
5.000
112
47.527
26.250
32
18.798
15.000
136
21.184
15.000
2
0.089
0.200
131
0.004
0.020
942
0.001
0.020
143
0.624
1.500
556
0.126
1.500
246
1.126
2.000
880
1.698
3.000
272
2.874
4.500
236
0.400
0.306
2.256
32
329
20
82.05
2.2
20.0
3HFF
5811
5811
1.0
1.0
0.059
1
14.35
4.7
93.2
0.49
2.2
2.3
2.17
623
1
3.0
82.7
data collection
MAR345
phasing
PHASER
refinement
REFMAC
5.5.0044
data reduction
XDS
data scaling
XDS
Monomeric human Cu,Zn Superoxide dismutase without Zn ligands
1
N
N
2
N
N
2
N
N
2
N
N
2
N
N
2
N
N
3
N
N
The oligomeric state predicted by PISA is a putative dimer.
metalc
2.228
A
ALA
1
A
N
ALA
1
1_555
A
ZN
156
D
ZN
ZN
1_555
metalc
2.231
A
ALA
1
A
O
ALA
1
1_555
A
ZN
156
D
ZN
ZN
1_555
metalc
1.982
A
HIS
46
A
ND1
HIS
46
1_555
A
ZN
154
B
ZN
ZN
1_555
metalc
1.813
A
ASP
90
A
OD2
ASP
90
1_555
A
ZN
155
C
ZN
ZN
1_555
metalc
2.057
A
HIS
110
A
NE2
HIS
110
1_555
A
ZN
158
E
ZN
ZN
1_555
metalc
1.954
A
HIS
120
A
NE2
HIS
120
1_555
A
ZN
154
B
ZN
ZN
1_555
metalc
1.993
A
ASP
125
A
OD2
ASP
125
1_555
A
ZN
159
F
ZN
ZN
1_555
metalc
2.126
A
ZN
154
B
ZN
ZN
1_555
A
HOH
211
G
O
HOH
1_555
metalc
2.351
A
ZN
155
C
ZN
ZN
1_555
A
HOH
208
G
O
HOH
1_555
metalc
2.151
A
ZN
156
D
ZN
ZN
1_555
A
HOH
206
G
O
HOH
1_555
metalc
2.316
A
ZN
156
D
ZN
ZN
1_555
A
HOH
209
G
O
HOH
1_555
metalc
1.898
A
ZN
159
F
ZN
ZN
1_555
A
HOH
219
G
O
HOH
1_555
OXIDOREDUCTASE
OXIDOREDUCTASE, SOD1, MONOMERIC MUTANT, Amyotrophic lateral sclerosis, Antioxidant, Disease mutation, Disulfide bond, Metal-binding, Neurodegeneration, Phosphoprotein
SODC_HUMAN
UNP
1
2
P00441
ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERH
VGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ
2
154
3HFF
1
153
P00441
A
1
1
153
1
CYS
engineered mutation
ALA
6
3HFF
A
P00441
UNP
7
6
1
PHE
engineered mutation
GLU
50
3HFF
A
P00441
UNP
51
50
1
GLY
engineered mutation
GLU
51
3HFF
A
P00441
UNP
52
51
1
HIS
engineered mutation
SER
63
3HFF
A
P00441
UNP
64
63
1
HIS
engineered mutation
SER
71
3HFF
A
P00441
UNP
72
71
1
HIS
engineered mutation
SER
80
3HFF
A
P00441
UNP
81
80
1
ASP
engineered mutation
SER
83
3HFF
A
P00441
UNP
84
83
1
CYS
engineered mutation
ALA
111
3HFF
A
P00441
UNP
112
111
8
6
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
GLY
82
A
GLY
82
A
ALA
89
A
ALA
89
A
GLY
41
A
GLY
41
A
VAL
47
A
VAL
47
A
THR
116
A
THR
116
A
HIS
120
A
HIS
120
A
ARG
143
A
ARG
143
A
VAL
148
A
VAL
148
A
THR
2
A
THR
2
A
GLY
10
A
GLY
10
A
GLN
15
A
GLN
15
A
GLN
22
A
GLN
22
A
VAL
29
A
VAL
29
A
LYS
36
A
LYS
36
A
ALA
95
A
ALA
95
A
ASP
101
A
ASP
101
A
GLY
82
A
GLY
82
A
ALA
89
A
ALA
89
A
GLY
41
A
GLY
41
A
VAL
47
A
VAL
47
A
THR
116
A
THR
116
A
HIS
120
A
HIS
120
A
ARG
143
A
ARG
143
A
VAL
148
A
VAL
148
A
THR
2
A
THR
2
A
GLY
10
A
GLY
10
A
GLY
150
A
GLY
150
A
ILE
151
A
ILE
151
BINDING SITE FOR RESIDUE ZN A 154
A
ZN
154
Software
4
BINDING SITE FOR RESIDUE ZN A 155
A
ZN
155
Software
5
BINDING SITE FOR RESIDUE ZN A 156
A
ZN
156
Software
4
BINDING SITE FOR RESIDUE ZN A 158
A
ZN
158
Software
4
BINDING SITE FOR RESIDUE ZN A 159
A
ZN
159
Software
3
A
HIS
46
A
HIS
46
4
1_555
A
HIS
120
A
HIS
120
4
1_555
A
HOH
211
G
HOH
4
1_555
A
HOH
212
G
HOH
4
1_555
A
ASP
90
A
ASP
90
5
1_555
A
ASP
92
A
ASP
92
5
1_555
A
HOH
204
G
HOH
5
4_545
A
HOH
207
G
HOH
5
1_555
A
HOH
208
G
HOH
5
1_555
A
ALA
1
A
ALA
1
4
1_555
A
ASP
96
A
ASP
96
4
4_655
A
HOH
206
G
HOH
4
1_555
A
HOH
209
G
HOH
4
1_555
A
ASP
11
A
ASP
11
4
1_565
A
HIS
110
A
HIS
110
4
1_555
A
HOH
220
G
HOH
4
1_565
A
HOH
222
G
HOH
4
1_555
A
ASP
125
A
ASP
125
3
1_555
A
HOH
216
G
HOH
3
1_555
A
HOH
219
G
HOH
3
1_555
152
P 31 2 1